Pharma & Biotech

Novo Nordisk shares experienced significant volatility during Thursday's trading session as conflicting forces buffeted the Danish pharmaceutical leader. While regulatory...

Pfizer has emerged with significant developments in cancer treatment that could reshape therapeutic approaches while potentially reversing the pharmaceutical giant's...

The healthcare conglomerate Johnson & Johnson is currently experiencing a powerful convergence of favorable analyst sentiment and significant clinical achievements....

Biotechnology firm Incyte has emerged as a significant new contender in cancer research, propelled by two separate clinical trial breakthroughs...

While technology stocks face headwinds, an animal health specialist is demonstrating remarkable resilience. Zoetis has reported quarterly results that substantially...

While numerous biotechnology companies face challenging market conditions, Abeona Therapeutics is distinguishing itself with a series of promising developments. From...

The weight-loss pharmaceutical sector experienced significant turbulence following a social media post from former President Donald Trump. His call for...

A dramatic financial showdown is unfolding around Intellia Therapeutics, where extreme market pessimism collides with groundbreaking medical innovation. The biotech...

Johnson & Johnson is undertaking a profound strategic shift, moving away from its established business model through a significant divestment....

NuCana plc witnessed dramatic trading activity on Wednesday, with its shares swinging by more than 15% before ultimately closing nearly...